Novo Nordisk presents results from STRIDE study on Ozempic
Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...
The Ozempic workout? How gyms and trainers are catering to a new group of exercisers
Equinox's GLP-1 protocol is considered a framework for people taking the drugs, one that addresses workout intensity, ...
The Case For Hims & Hers: Diversification And Growth Beyond Semaglutide
Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.
verywellhealth14d
High Platelet Count Causes and Treatment
A high platelet count, or thrombocytosis, is diagnosed when platelet levels are greater than 450,000 platelets per microliter of blood. A high platelet count can lead to symptoms that range from ...
TechRadar14d
Click Frenzy 2025: the Mayhem will arrive soon – here's what you need to know about the next sale
The first Click Frenzy sale of 2025 – known as PayPal Frenzy – has been and gone, and it certainly delivered on the deals front. Fortunately, they're not stopping anytime soon as the next ...
MarketWatch15d
Here’s why Ozempic maker’s new weight-loss drug isn’t good enough for investors
Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...
Hosted on MSN18d
Thank God I’ve stopped microdosing Ozempic – this is what it’s really like
Never mind! Let’s face it “microdosing”sounds so much more palatable and tempting than going full-throttle Ozempic. But take it from me, it’s not. Counting the clicks is no way to live. I threw the ...
The Independent18d
Thank God I’ve stopped microdosing Ozempic – this is what it’s really like
Never mind! Let’s face it “microdosing”sounds so much more palatable and tempting than going full-throttle Ozempic. But take it from me, it’s not. Counting the clicks is no way to live.